We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience. You can read our Cookie Policy here.


INC Research Expands Alliance Partnership Executive Team With New VP in Europe

Want a FREE PDF version of This News Story?

Complete the form below and we will email you a PDF version of "INC Research Expands Alliance Partnership Executive Team With New VP in Europe"

First Name*
Last Name*
Email Address*
Company Type*
Job Function*
Would you like to receive further email communication from Technology Networks?

Technology Networks Ltd. needs the contact information you provide to us to contact you about our products and services. You may unsubscribe from these communications at any time. For information on how to unsubscribe, as well as our privacy practices and commitment to protecting your privacy, check out our Privacy Policy

Read time:
 "We have experienced a very positive response to our alliance partnership program from sponsors of every type and size because of the economic advantages and focus on mutual goals and alignment," said Alistair Macdonald, executive vice president, Strategic Development at INC Research. "Manfred has the right scientific and strategic background to create alliance models that fit the unique requirements represented across the breadth of our current and prospective customer base. We believe clinical delivery alliances are the natural evolution in our industry and we are dedicated on being drivers of that innovation."

Dr. Weiler has a solid track record in life sciences with experience in building market-leading organizations. Prior to INC Research, he held management positions with SGS Group Management where he led its global CRO Business Development department with teams in Europe, US and Asia. At QIAGEN, he was responsible for the strategy, marketing, and future product developments of a joint venture of QIAGEN GmbH and Becton Dickinson, Inc., Franklin Lakes, USA. Dr. Weiler earned his Ph.D. degree in Biochemistry at the University of Bonn.

INC Research's clinical delivery alliance structures can include complete management of a compound or therapeutic area; management of a specific function or set of critical processes; sharing in the risk and reward of a compound's performance; or acting as the sole source development partner for a customer. The company's proven experience with process-driven clinical research methods and its popular metrics-based Trusted Process(R) provides the foundation for successful strategic alliances.